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As obligate intracellular parasites, viruses are exclusively and intimately dependent upon
their host cells for replication. During replication viruses induce profound changes within
cells, including: induction of signaling pathways, morphological changes, and cell death.
Many such cellular perturbations have been analyzed at the transcriptomic level by
gene arrays and recent efforts have begun to analyze cellular proteomic responses.
We recently described comparative stable isotopic (SILAC) analyses of reovirus, strain
type 3 Dearing (T3D)-infected HeLa cells. For the present study we employed the
complementary labeling strategy of iTRAQ (isobaric tags for relative and absolute
quantitation) to examine HeLa cell changes induced by T3D, another reovirus strain, type
1 Lang, and UV-inactivated T3D (UV-T3D). Triplicate replicates of cytosolic and nuclear
fractions identified a total of 2375 proteins, of which 50, 57, and 46 were significantly
up-regulated, and 37, 26, and 44 were significantly down-regulated by T1L, T3D, and
UV-T3D, respectively. Several pathways, most notably the Interferon signaling pathway
and the EIF2 and ILK signaling pathways, were induced by virus infection. Western
blots confirmed that cells were more strongly activated by live T3D as demonstrated
by elevated levels of key proteins like STAT-1, ISG-15, IFIT-1, IFIT-3, and Mx1. This study
expands our understanding of reovirus-induced host responses.
Keywords: RNA virus, virus infection, host cell alterations, mass spectrometry, liquid chromatography, cell
signaling, bioinformatics
Introduction
The mammalian orthoreoviruses (MRV) are non-enveloped viruses that contain a genome com-
prising 10 segments of double-stranded (ds)RNA. The dsRNA genome is enclosed in a concentric
double-layered protein capsid built from eight different viral structural proteins. For reviews, see
Danthi et al. (2010), Coombs (2011b), and Dermody et al. (2013). MRV are the prototype mem-
bers of the family Reoviridae, genus Orthoreovirus. The Ortheoreoviruses include fusogenic avian
reovirus and non-fusogenic MRV and the Reoviridae family also contains rotaviruses (Estes and
Kapikian, 2007), orbiviruses (Roy, 2007), and at least 10 other genera, divided into two sub-families
based upon particle morphology (Mertens et al., 2005; Coombs, 2011b; Dermody et al., 2013). MRV
infections are generally mild in humans but most other family members are highly pathogenic
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in their respective hosts. MRV currently consist of three generally
studied serotypes, with each represented by a prototype strain:
strain Lang (T1L) for serotype 1; strain Jones (T2J) for serotype
2, and strain Dearing (T3D) for serotype 3. A possible fourth
strain, Ndelle virus, has also been proposed (Attoui et al., 2001).
MRV have long served as models for understanding viral patho-
genesis (Dermody et al., 2013) and they may also be oncolytic
agents (Coffey et al., 1998; Forsyth et al., 2008; Thirukkumaran
et al., 2010) because of their capacity to selectively kill cancer cells
that contain functional p53 and an activated Ras pathway (Coffey
et al., 1998; Pan et al., 2011).
Virus infection induces numerous alterations in cells. Many
such alterations have been detected and measured at the mRNA
level by gene array analyses (see for example, Geiss et al.,
2002; Poggioli et al., 2002; Debiasi et al., 2003; Kobasa et al.,
2007; Tyler et al., 2010). However, since mRNA levels cannot
provide complete information about types of post-translational
modifications or levels of protein synthesis, the utility of such
studies for predicting cellular proteomic responses is usually
limited (Pradet-Balade et al., 2001; Tian et al., 2004; Baas
et al., 2006). Therefore, quantitative and comparative proteomic
analyses have been used to provide complementary informa-
tion about host responses to virus infection (reviewed in Yates
et al., 2009; Coombs, 2011a). Commonly used methods include
2-dimensional difference in gel electrophoresis (2D-DIGE (see
for examples, Burgener et al., 2008; Lucitt et al., 2008), and
newer non-gel-based strategies such as stable isotope label-
ing by amino acids in cell culture (SILAC, Ong et al., 2002;
de Hoog et al., 2004; Everley et al., 2004; Yan et al., 2004;
Ong and Mann, 2005), isotope coded affinity tags (ICAT, Booy
et al., 2005; Stewart et al., 2006), and isobaric tags for rela-
tive and absolute quantitation (iTRAQ, Dwivedi et al., 2009;
Zhang et al., 2009). Li and colleagues used 2D-DIGE of MRV-
infected murine myocytes and found regulation of several pro-
teins, including heat shock proteins and interferon-response
proteins (Li et al., 2010). We previously used SILAC to label
reovirus T1L-infected HEK293 cells (Berard et al., 2012) and
T3D-infected HeLa cells (Jiang et al., 2012; Coombs, 2013) with
light and heavy isotopic arginine and lysine to compare these
infected cells to reciprocally-labeled mock-infected cells. The
non-gel-based approaches generally identify more proteins than
the gel-based approaches and also are usually better at mea-
suring down-regulated proteins (Yates et al., 2009; Coombs,
2011a). SILAC is a simple and straightforward method but is
usually limited to analyzing and comparing a limited number
of samples. By contrast, iTRAQ (Choe et al., 2005; Prange and
Proefrock, 2008) allows simultaneous analysis of four or more
samples.
The above SILAC analyses successfully identified and mea-
sured several thousand host proteins, many of which are involved
in cell death, cell growth and proliferation, molecular trans-
port, gene expression, and inflammatory response pathways
(Berard et al., 2012; Jiang et al., 2012; Coombs, 2013) but
the cellular proteomic repertoire is several orders of magni-
tude larger. In addition, the non-gel-based strategies, which
generally successfully identify significantly more proteins than
the gel-based 2D-DIGE strategies (Yates et al., 2009; Coombs,
2011a), were used to analyze single reovirus strains. Thus, as
part of an ongoing systematic effort to delineate reovirus-induced
host protein responses, we extended our proteomic analyses
by examining multiple reovirus clones and by using a comple-
mentary approach. Although there are 3–4 reovirus serotypes,
the most extensively studied are T1L and T3D. In addition,
cellular perturbations, including signaling, may be caused by
active viral replication, induced by live virus, or by engage-
ment of non-infectious virus with intracellular and extracel-
lular components. Thus, we chose to take advantage of the
multi-plexing capacity of iTRAQ by analyzing live T1L- and
T3D-infected cells, and comparing responses to mock and dead
T3D, a total of four conditions. We identified and measured
2375 proteins with two or more peptides at >99% confidence
and found that 137 were significantly quantitatively regulated.
There also were major differences in the proteins and path-
ways induced by T1L, T3D, and UV-T3D. For example, T3D
induced significant up-regulation of several proteins in the
Interferon signaling pathway, including STAT-1, IFIT-1, IFIT-3,
and Mx1.
Materials and Methods
Cells and Viruses
Cell Lines and Media
Mouse L929 fibroblast cells (L929) were grown in Joklik’s suspen-
sion minimal essential medium (J-MEM) (Gibco, Grand Island,
NY) supplemented to contain 5% fetal bovine serum (FBS) (Invit-
rogen Canada Inc., Burlington, Ontario), and 2mM L-glutamine
as described (Berard and Coombs, 2009). Cells were sub-cultured
daily. Human HeLa cells were cultured as monolayers in Dul-
becco’s modified MEM (D-MEM) supplemented with 0.2% (w/v)
glucose, 10% FBS (Invitrogen), 2mM l-glutamine, non-essential
amino acids, and sodium pyruvate as described (Coombs, 2013).
Cells were sub-cultured 2–3 times each week.
Viruses
Reovirus strain type 1 Lang (T1L) and type 3 Dearing-Fields
(T3D) are laboratory stocks. Virus stocks were usually grown
in L929 cell monolayers in J-MEM in the presence of 5% CO2
at 37◦C as above, but with 3% FBS, 100U/ml of penicillin,
100µg/ml streptomycin sulfate, and 100µg/ml amphotericin-B
as previously described (Berard and Coombs, 2009). Virus titers
were determined on L929 monolayers as described (Berard and
Coombs, 2009).
Virus Purification
Large quantities of reovirus T1L and T3D were grown in sus-
pension L929 cell cultures and purified by routine Vertrel-XF™
extraction and cesium chloride ultracentrifugation procedures
(Mendez et al., 2000). Gradient-purified virions were harvested,
dialyzed against 2× SSC Buffer (150mM NaCl, 15mM Na-
citrate, pH 7.0) and virus concentrations were measured spec-
trophotometrically, using the relationship 1 ODU260 = 2.1 ×
1012 particles/ml (Smith et al., 1969). Aliquots of purified T3D
were inactivated by exposure to an ultra-violet light box. Non-
treated T1L and T3D infectivity, and UV-induced T3D loss of
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infectivity, were confirmed by plaque assay (Berard and Coombs,
2009).
Infections
For non-iTRAQ analyses (i.e., for Western blot validation—see
below), cells were mock-treated or were infected with T1L, T3D,
or UV-T3D, harvested at specified time points, and fraction-
ated as described below. For iTRAQ labeling, sets of HeLa cells
were infected with gradient-purified T1L or T3D at a multiplic-
ity of infection (MOI) of seven PFU per cell, or with an equal
number of UV-inactivated T3D (UV-T3D) particles, or were
mock-infected with diluent. Experiments were performed three
times.
Cell Fractionation
Infected and mock-infected cells were harvested at various
times post-infection. Harvested cells were washed three times
in >50 volumes of ice-cold Phosphate Buffered Saline (PBS).
Three times-washed cells were resuspended in ice-cold PBS
supplemented with 1.5 times Complete™ Protease Inhibitor
(Pierce) at a concentration of ∼107 cells per 0.3ml and cells
were lysed by the addition of one-tenth volume of 5% NP-40.
Cells were incubated for 30min with periodic mixing and nuclei
pelleted at 500 × g for 10min. Supernatants (cytosol and soluble
membranes) were transferred to fresh tubes and the nuclei were
washed four times with PBS + 0.25 times Complete™ Protease
Inhibitor + 10% sucrose. Washed nuclei were extracted by a
two-step MS-compatible high salt/urea procedure (Kroeker
et al., 2012). Each fraction was desalted using HiTrap desalting
column connected to an AKTA FPLC (GE). Protein content in
every cytosolic and nuclear fraction was determined by BCA
Protein Assay (Pierce) using bovine serum albumin standards.
The cytosolic and nuclear fractions were stored at −80◦C until
further processing took place.
Immunoblotting
Equivalent cytosolic and nuclear fractions were resolved in 10%
linear mini sodium dodecyl sulfate polyacrylamide gels (SDS-
PAGE, 8.0 × 6.5 × 0.1 cm) at 180V for 60min. Proteins were
transferred to 0.2µm polyvinylidene difluoride (PVDF) mem-
branes at 20V for 40min with a Semi-dry apparatus (BioRad),
and protein transfer was confirmed by Ponceau-S staining. The
membranes were blocked with 5% (w/v) skim milk in Tris-
buffered saline with Tween-20 (TBST; 50mM Tris, 150mM
NaCl, 0.05% Tween 20, pH 7.4) and probed with various
primary antibodies. Primary antibodies were: in-house pro-
duced rabbit anti-reovirus, rabbit α-GAPDH (Cell Signaling,
cat#2118), α-ISG15 (Rockland, cat#200-401-438), and α-IFIT
(Abcam, cat#ab55837); goat α-Mx1 (Santa Cruz #sc-34128); and
mouse α-Actin (Sigma, cat#A5441), and α-STAT1 (Cell Signal-
ing, cat#9176). Appropriate secondary horseradish peroxidase
(HRP)-conjugated horse anti-mouse or goat anti-rabbit (Cell
Signaling, cat#7076, cat#7074, respectively), or rabbit anti-goat
(Zymed, cat#81-1620) were used to detect immune complexes.
Bands were developed by enhanced chemiluminescence and
imaged with an Alpha Innotech FluorChemQ MultiImage III
instrument.
Comparative iTRAQ Analyses
Protein Digestion and Peptide Fractionation
Fractionated samples were labeled with iTRAQ according to
the manufacturer’s instructions (Applied Biosystems, Foster City,
CA, USA) and by routine procedure as previously described
(Dwivedi et al., 2009; Summers et al., 2012). Briefly, for each
sample, 100µg of protein was mixed with 100mM ammonium
bicarbonate, reduced with 10mM dithiothreitol, and incubated
at 57◦C for 30min. Proteins were then alkylated with 50mM
iodoacetamide in the dark at room temperature for 30min.
Excess iodoacetamide was quenched with 17mM dithiothreitol.
Peptides were digested with one-fiftieth trypsin (w/w; Promega,
Madison, WI) at 37◦C for 10 h. Samples were then acidified with
an equal volume of 3% trifluoroacetic acid (TFA), lyophilized,
and re-suspended in 200µL of 0.1% TFA. Samples were loaded
on a C18 X-Terra column (1×100mm, 5µm, 100Å;Waters Cor-
poration, Milford, MA, USA), desalted using 0.1% TFA, and pep-
tides eluted with 50% acetonitrile. Desalted samples were stored
at −80◦C for 2D-HPLC-MS/MS analysis. For comparative pro-
teomic analysis, each peptide sample (100µg) was labeled with
isobaric Tags for Relative and Absolute Quantitation (iTRAQ)
reagent (Applied Biosystems, Foster City, CA, USA) as out-
lined by the manufacturer. For two experimental replicates, the
cytosolic or nuclear fractions were labeled with either the “even”-
numbered probes (MW = 114, 116, 118, 121) of an iTRAQ 8-
plex reagent kit or with the odd-numbered probes (MW = 113,
115, 117, 119). For the third experimental replicate, the cytoso-
lic and nuclear fractions were divided in half and each fraction
was labeled with all eight iTRAQ probes, providing four sets of
measurements for the three biological replicates.
Two-Dimensional High-Performance Liquid
Chromatography-Mass Spectrometry
Labeled peptides were mixed in equal proportions and sub-
jected to 2D-HPLC-MS/MS (Aggarwal et al., 2006; Zieske, 2006).
Trypsinized peptides were separated in the first dimension with
an Agilent 1100 Series HPLC system (Agilent Technologies,
Wilmington, DE). Samples were injected onto a C18 X-Terra
column (1 × 100mm, 5µm, 100Å; Waters Corporation, Mil-
ford, MA, USA) and eluted with a linear water-acetonitrile gra-
dient (20mM ammonium formate, pH 10, in both eluents A and
B, 1% acetonitrile/min, 150µL/min flow rate). A concentrated
200mM solution of ammonium formate at pH 10 was prepared
as described by Gilar et al. (2005). For first-dimension separation,
Buffers A and Bwere prepared by a one-tenth dilution of this con-
centrated buffer with water and acetonitrile, respectively. Fifty
1-min cytoplasmic fractions were collected (≈6.6µg/fraction).
Samples were concatenated (fraction 1 and 26, 2 and 27, etc.)
into a total of 25 fractions as described by Dwivedi et al. (2008)
and each concatenated fraction was lyophilized and re-suspended
in 100µL of 0.1% formic acid. Because of lower protein content,
nuclear samples were collected as 30 1-min fractions and con-
catenated into 15 combined fractions. Protein content in each
concatenated sample was determined by Nanodrop R© and 2µg
of each peptide fraction was separated in the second dimen-
sion on a splitless nanoflow Tempo LC system (Eksigent, Dublin,
CA, USA) with 20µL sample injection via a 300µm × 5mm
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PepMap100 precolumn and a 100µm × 150mm analytical col-
umn packed with 5µm Luna C18(2) (Phenomenex, Torrance,
CA). Both eluents A (2% acetonitrile in water) and B (98% ace-
tonitrile) contained 0.1% formic acid as ion pairing modifier. A
0.33% acetonitrile/min linear gradient (0–30% B) was used for
peptide elution, providing a total 2 h run time per fraction in the
second dimension.
Mass Spectrometry
A QStar Elite mass spectrometer (Applied Biosystems, Foster
City, CA) was used in standard MS/MS data dependent acquisi-
tionmode with a nano-electrospray ionization source operated in
positive ion mode. One-second survey MS spectra were collected
(m/z 400–1500) followed by three MS/MS measurements on the
most intense parent ions (80 counts/s threshold,+2 to+4 charge
state, m/z 100–1500 mass range for MS/MS), using the manu-
facturer’s iTRAQ and “smart exit” settings. Previously targeted
parent ions were excluded from repetitive MS/MS acquisition for
60 s (50 mDa mass tolerance). Standard QTOF search settings
were used: 100 ppm and 0.4Da mass tolerance for parent and
fragment ions, respectively.
Database Search, Protein Identification, and
Statistical Analysis
Raw spectra
WIFF files containing MS and MS/MS data were analyzed
using Protein Pilot 4.0 software using Paragon algorithm
(Applied Biosystems). Protein identification and quantifi-
cation search parameters were as follows: iTRAQ 4-plex
(peptide labeled) or iTRAQ 8-plex (peptide labeled), car-
bamidomethylation of cysteine. Information for all 25
fractions of each sample were searched against human gene
database (NCBI released March 2011, downloaded from
ftp://ftp.ncbi.nih.govrefseqH_sapiensmRNA_Prot, containing
37,391 entries). Proteins, their confidences, and their expression
ratios, expressed as infected: mock (I:M), were returned with
gi accession numbers. Proteins identified at >99% confidence
(Unused Score >2.00) for which peptides were detected at >95%
confidence were used for subsequent comparative quantitative
analysis. The false discovery rate (FDR), defined as the per-
centage of reverse proteins identified against the total protein
identification, was determined to be <0.8%.
Each of the 24 datasets were normalized, essentially as
described (Keshamouni et al., 2009; Coombs et al., 2010) to allow
dataset merging and comparison. Briefly, every infected-to-mock
(I:M) ratio was converted into log2 space, geometric means and
standard deviations of each dataset were calculated, and every
protein’s log2 I:M ratio was converted into a z-score, using the
formula:
z-score (σ) of
[
b
]
=
Log2I : M[b]− Average of
(
log2 of each member, a . . . .n
)
Standard deviation of
(
log2 of each member, a . . . .n
)
where “b” represents an individual protein in the dataset a. . . .n,
and z-score represents the number of standard deviation units
(expressed as “σ”) that protein’s log2 I:M ratio is from its popula-
tion mean. Thus, a protein with a z-score >1.960 σ indicates that
protein’s differential expression lies outside the 95% confidence
level, >2.576 σ indicates outside the 99% confidence level, and
3.291 σ indicates 99.9% confidence. z-Scores>1.960 were consid-
ered significant. Gi numbers of all significantly regulated proteins
were converted into HGNC identifiers by Uniprot (http://www.
uniprot.org/) and HGNC terms were submitted to and analyzed
by STRING (Von Mering et al., 2007; Szklarczyk et al., 2011)
and by the DAVID bioinformatic suite at the NIAID, version
6.7 (Dennis et al., 2003; Huang et al., 2009) and gene ontolo-
gies examined with the “FAT” datasets. The gi numbers were also
submitted to, and pathways constructed with, Ingenuity Pathway
Analysis software (IPA™).
Results
T1L, T3D, and UV-T3D Induce Different Host
Protein Regulation
Titration of the gradient-purified virions and comparisons to
optically-determined particle counts indicated that the particle-
to-PFU ratios of the various virus samples were: T1L: 191; T3D:
327; and UV-treated T3D: >3.5× 108, respectively. These differ-
ent virus preparations were then used to infect HeLa cells, cells
were harvested at 24 hpi, and cytosolic and nuclear fractions pre-
pared and analyzed as described in Materials and Methods. After
removal of proteins identified at <99% confidence and those
identified by a single peptide, a total of 1562, 1794, and 1599
proteins were detected and relative quantities measured in the
two 4-plex and one 8-plex cytosolic fractions, respectively, and
654, 650, and 782 proteins were measured in the correspond-
ing nuclear fractions (Figure 1A, left and center). 1491 proteins
were found exclusively in the cytosol, 340 were found just in the
nucleus, and 544 were found in both fractions (Figure 1A, right).
Experimental variability was also assessed by examination of the
8-plex technical replicates. The two mock samples were com-
pared to each other and to the various infections (Figure 1B). The
standard deviations of Infected:Mock Log2 ratios were 0.051 and
0.034 for the cytosolic and nuclear Mock replicates, respectively,
and 3.9- to 14-fold higher for each of the infected samples, indi-
cating that host protein ratios were greatly affected by the virus
treatments.
Each dataset was subjected to Z-score analysis to identify pro-
teins that were significantly regulated. This analysis indicated that
fold changes of±1.29 to±1.56 (depending upon specific dataset)
could be considered significant. Thus, for further consideration,
protein regulation needed to exceed ±1.29 and have a Z-score
>1.960 or <-1.960. A total of 137 proteins appeared to be regu-
lated by one or more of the virus preparations (Table 1). Twenty
nine proteins were significantly up-regulated in the cytosolic frac-
tions by T1L and 18 nuclear proteins were also up-regulated by
T1L. BAF, the barrier to autointegration factor 1, was detected
and found to be up-regulated in both fractions by T1L infection.
Sixteen cytosolic and 14 nuclear proteins were found to be down-
regulated, with no down-regulated proteins appearing in both
fractions. Similarly, T3D infection resulted in determination of
32 up-regulated proteins in the cytosol and 19 up-regulated in
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FIGURE 1 | Distributions of proteins identified in various
experiments. (A) Venn diagrams of numbers of identified proteins from
various experimental replicates and cell fractions. Cells that were mock
infected, or infected with reovirus T1L or T3D, or treated with
UV-inactivated T3D, were harvested at 24 hpi, fractionated into the
cytosolic (Cyto, left) and nuclei (Nuc, center) fractions and labeled with
iTRAQ reagents. Numbers of proteins identified with two or more
peptides and at >99% confidence are indicated for each of the three
experimental replicates. The total numbers of unique proteins identified in
the cytosolic and nuclear fractions are indicated at right. (B) Frequency
distributions of identified proteins and their expression ratios (expressed
as Log2 fold change compared to Mock) in representative 8-plex iTRAQ
samples. The two mock samples were compared to each other and to
each of the other six treatments. Standard deviations of the variance in
each cytoplasmic (left) and nuclear (right) sample are shown in the box
in each plot. The two thin vertical lines represent ±7 σ, corresponding to
the limits within which virtually all mock samples fall. Positive values
represent up-regulated host proteins in virus-infected cells; negative
values represent down-regulated host proteins. Only the distributions of
one set of each treatment are shown for clarity.
the nucleus, with caltractin up-regulated in both fractions, and
10 and 11 down-regulated proteins in the cytosolic and nuclear
fractions, respectively. UV-inactivated T3D treatment of cells
resulted in 22 up-regulated proteins in the cytoplasm, 17 up-
regulated in the nucleus, 19 down-regulated in the cytoplasm,
and 17 down-regulated in the nucleus.
Several proteins were similarly regulated by all three virus
treatments. Cytosolic FIS1, cytochrome c, LDHA, E2AK2,
AT1B3, H2A1A, ARF3, VATC1, and nuclear STIP1, RS28,
CN166, AHNK, RU1C, RS12, BAG2, TCP4, and DAZP1 were
up-regulated by both live T1L and T3D and by inactivated
T3D (Table 1). Cytosolic CND2, ITB4, USP9X, and nuclear
H2B3B, RPB9, H32, and DCD were down-regulated by all
three virus types. Many proteins were differentially regulated
by only some of the three virus types. Nuclear syntenin iso-
form 1 (SDCB1) was not detected, but cytosolic SDCB1 was
strongly up-regulated by T3D, weakly up-regulated by T1L,
and down-regulated by UV-T3D. Several proteins were differ-
entially regulated by one virus serotype but not by the other
virus serotype. For example, T1L induced up-regulation of more
than a dozen proteins (including RM44, ERH, DHAK, BAF, and
EF2) but T3D did not induce significant alterations in levels of
these proteins. Conversely, T3D induced strong up-regulation
of four cytosolic immune-regulated proteins (Mx1, ISG15,
IFIT1, and STAT-1) and up-regulation of more than a dozen
other proteins (including IFIT3, CETN2, RBP2, and DDX58),
but T1L induced non-significant changes in these proteins’
levels.
Validation of Protein Ratios by Western Blotting
To confirm some of the iTRAQ-determined protein ratios,
we analyzed selected proteins in T1L- and T3D-infected,
and UV-T3D-treated, cells. Immunoblotting confirmed that
STAT-1, ISG15, IFIT1, and Mx1 were strongly up-regulated
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TABLE 1 | Significantly-regulated HeLa cell proteins.
Accession HGNC Name Cytosol Nucleus
T1L T3D T3-UV T1L T3D T3-UV
gi|24308273 ABRAL Hypothetical protein LOC58527 4.0 3.1 – nd nd nd
gi|151108473 FIS1 Tetratricopeptide repeat domain 11 3.9 4.3 3.5 nd nd nd
gi|11128019 CYC Cytochrome c 3.7 2.3 2.4 nd nd nd
gi|27734984 HYPK Chromosome 15 open reading frame 63 3.6 2.8 – nd nd nd
gi|12597661 RM44 Mitochondrial ribosomal protein L44 3.0 – – – – –
gi|5032057 S10AB S100 calcium binding protein A11 2.8 3.3 – – – –
gi|5031857 LDHA L-lactate dehydrogenase A isoform 1 2.7 1.9 2.3 nd nd nd
gi|4506103 E2AK2 Eukaryotic translation initiation factor 2-alpha kinase 2 isoform a 2.6 6.4 2.7 – – –
gi|4502281 AT1B3 Na+/K+-ATPase beta 3 subunit 2.4 3.0 1.7 nd nd nd
gi|4758302 ERH Enhancer of rudimentary homolog 2.2 – 2.6 – – –
gi|25092737 H2A1A Histone cluster 1, H2aa 2.1 1.6 2.4 nd nd nd
gi|4502203 ARF3 ADP-ribosylation factor 3 2.0 1.7 1.8 nd nd nd
gi|20149621 DHAK Dihydroxyacetone kinase 2 1.9 – – nd nd nd
gi|22547114 RM10 Mitochondrial ribosomal protein L10 precursor 1.7 – – nd nd nd
gi|21536476 DPH2 Diphthamide biosynthesis protein 2 isoform a 1.7 2.1 – nd nd nd
gi|94721241 SYIC Isoleucine tRNA synthetase 1.7 – – nd nd nd
gi|4506741 RS7 Ribosomal protein S7 1.7 – – – – –
gi|4502315 VATC1 ATPase, H+ transporting, lysosomal V1 subunit C1 1.6 1.8 1.8 nd nd nd
gi|4502389 BAF Barrier to autointegration factor 1 1.5 – 1.4 2.8 2.6 2.4
gi|4504263 H2B1M Histone cluster 1, H2bm 1.5 – 1.7 nd nd nd
gi|4503483 EF2 Eukaryotic translation elongation factor 2 1.5 – – nd nd nd
gi|5803225 1433E Tyrosine 3/tryptophan 5-monooxygenase activation protein, epsilon polypeptide 1.5 – 1.5 – – –
gi|21361399 2AAA Alpha isoform of regulatory subunit A, protein phosphatase 2 1.5 – – nd nd nd
gi|19923951 C10 C10 protein 1.4 – – nd nd nd
gi|22748937 XPO5 Exportin 5 1.4 1.7 – nd nd nd
gi|6912486 LSM4 U6 snRNA-associated Sm-like protein 4 1.4 – – – – –
gi|56243522 SDCB1 Syntenin isoform 1 1.4 4.5 0.69 nd nd nd
gi|50592994 THIO Thioredoxin 1.4 – – – – –
gi|61966781 PTRD1 Hypothetical protein LOC391356 1.3 – – nd nd nd
gi|222136619 MX1 Myxovirus resistance protein 1 – 9.0 0.66 nd nd nd
gi|4826774 ISG15 ISG15 ubiquitin-like modifier – 6.7 – nd nd nd
gi|116534937 IFIT1 Interferon-induced protein with tetratricopeptide repeats 1 isoform 2 – 4.1 – nd nd nd
gi|6274552 STAT1 Signal transducer and activator of transcription 1 isoform alpha – 3.7 – nd nd nd
gi|41399285 CH60 Chaperonin – 2.5 – 2.1 – –
gi|72534658 IFIT3 Interferon-induced protein with tetratricopeptide repeats 3 – 2.5 0.48 nd nd nd
gi|4757902 CETN2 Caltractin – 2.2 – – 2.0 –
gi|22547138 RM04 Mitochondrial ribosomal protein L4 isoform a – 1.8 – nd nd nd
gi|32189394 ATPB Mitochondrial ATP synthase beta subunit precursor – 1.7 – – – –
gi|41393561 AMPL Leucine aminopeptidase 3 – 1.7 – nd nd nd
gi|7656991 COR1C Coronin, actin binding protein, 1C isoform 1 – 1.7 – – – –
gi|150418007 RBP2 RNA binding protein 2 – 1.7 – – – –
gi|47419916 SYWC Tryptophanyl-tRNA synthetase isoform a – 1.7 – nd nd nd
gi|208022641 ELOA1 Elongin A – 1.7 1.8 – – 2.1
gi|19913414 AP2A1 Adaptor-related protein complex 2, alpha 1 subunit isoform 1 – 1.6 – nd nd nd
gi|12025678 ACTN4 Actinin, alpha 4 – 1.6 – – – –
gi|27881482 DDX58 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide RIG-I – 1.6 – nd nd nd
gi|21361716 GLP3L Golgi phosphoprotein 3-like – – 3.1 nd nd nd
gi|77539758 H4 Histone cluster 2, H4b – – 1.9 – 0.51 –
gi|149274624 LBH Limb bud and heart development homolog – – 1.7 nd nd nd
(Continued)
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TABLE 1 | Continued
Accession HGNC Name Cytosol Nucleus
T1L T3D T3-UV T1L T3D T3-UV
gi|5803181 STIP1 Stress-induced-phosphoprotein 1 (Hsp70/Hsp90-organizing protein) – – 1.6 2.2 2.3 2.0
gi|93141020 H2AY H2A histone family, member Y isoform 2 – – 1.5 0.32 – –
gi|81295407 ACOT9 Acyl-Coenzyme A thioesterase 2, mitochondrial isoform a – – 1.5 nd nd nd
gi|4507357 TAGL2 Transgelin 2 – – 1.5 – – –
gi|12667788 MYH9 Myosin, heavy polypeptide 9, non-muscle – – 1.5 – – –
gi|197276602 MAP4* Microtubule-associated protein 4 isoform 5 – – 1.4 nd nd nd
gi|4506715 RS28 Ribosomal protein S28 – – – 3.7 3.1 3.3
gi|7706322 CN166 Homeobox prox 1 – – – 3.4 2.1 3.7
gi|61743954 AHNK AHNAK nucleoprotein isoform 1 – – – 2.9 2.4 2.7
gi|4507127 RU1C Small nuclear ribonucleoprotein polypeptide C nd nd nd 2.9 2.7 2.7
gi|42558250 CAPR1 Membrane component chromosome 11 surface marker 1 isoform 1 – – – 2.9 – –
gi|62750354 MATR3 Matrin 3 nd nd nd 2.6 – 2.7
gi|199559805 PPR18 Phostensin nd nd nd 2.5 – 2.2
gi|14277700 RS12 Ribosomal protein S12 – – – 2.4 2.5 2.3
gi|4757834 BAG2 BCL2-associated athanogene 2 – – – 2.4 2.3 2.4
gi|217330646 TCP4 Activated RNA polymerase II transcription cofactor 4 – – – 2.3 5.6 4.4
gi|4826760 HNRPF Heterogeneous nuclear ribonucleoprotein F – – – 2.3 – –
gi|25470886 DAZP1 DAZ associated protein 1 isoform b nd nd nd 2.2 2.2 2.3
gi|14211843 SCOC Short coiled-coil protein isoform 4 – – – 2.2 – 2.2
gi|60279268 U2AF2 U2 (RNU2) small nuclear RNA auxiliary factor 2 isoform b nd nd nd 2.0 – –
gi|10835063 NPM Nucleophosmin 1 isoform 1 – – – 2.0 2.0 –
gi|6005993 CLCA Clathrin, light polypeptide A isoform b – – – – 3.3 –
gi|4502899 CLCA Clathrin, light polypeptide A isoform a nd nd nd – 3.1 –
gi|49227854 MED10 Mediator complex subunit 10 nd nd nd – 2.7 2.9
gi|4504511 DNJA1 DnaJ (Hsp40) homolog, subfamily A, member 1 – – – – 2.2 –
gi|30795212 IF2B3 Insulin-like growth factor 2 mRNA binding protein 3 – – – – 1.9 –
gi|4503249 DEK DEK oncogene isoform 1 – 0.42 – – 1.1 –
gi|195972866 K1C10 Keratin 10 – 0.61 – – 0.6 –
gi|67782365 K2C7 Keratin 7 – – – – – 2.5
gi|41055989 MPP8 M-phase phosphoprotein 8 nd nd nd – – 2.2
gi|224586804 DPOE3 DNA-directed DNA polymerase epsilon 3 0.77 – – – – –
gi|14670354 GTF2I General transcription factor II, i isoform 3 0.69 – – – – –
gi|83627705 QCR6 Ubiquinol-cytochrome c reductase hinge protein 0.68 – 0.62 – – –
gi|94536842 RPIA Ribose 5-phosphate isomerase A 0.68 – – nd nd nd
gi|4557317 ANX11 Annexin A11 0.68 – – nd nd nd
gi|47271443 SRSF2 Splicing factor, arginine/serine-rich 2 0.66 – – – – –
gi|25121987 CND2 Non-SMC condensin I complex, subunit H 0.63 0.58 0.62 nd nd nd
gi|109633041 PTPRF Protein tyrosine phosphatase, receptor type, F isoform 1 precursor 0.62 – – nd nd nd
gi|9955963 ABCB6 ATP-binding cassette, sub-family B, member 6 0.62 – – nd nd nd
gi|10863895 TYB10 Thymosin, beta 10 0.61 – – nd nd nd
gi|71773329 ANXA6 Annexin VI isoform 1 0.58 – 0.56 nd nd nd
gi|187960100 UBE3C Ubiquitin protein ligase E3C 0.56 – – nd nd nd
gi|192455698 GPX8 Glutathione peroxidase 8 0.53 – – nd nd nd
gi|54607035 ITB4 Integrin beta 4 isoform 1 precursor 0.50 0.41 0.44 nd nd nd
gi|145309309 USP9X Ubiquitin specific protease 9, X-linked isoform 3 0.33 0.23 0.30 nd nd nd
gi|4503445 TYPH Endothelial cell growth factor 1 (platelet-derived) precursor 0.29 2.6 – nd nd nd
gi|194733742 NELFA Wolf-Hirschhorn syndrome candidate 2 protein – 0.77 – nd nd nd
gi|164664518 DDX6 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 – 0.70 – nd nd nd
gi|32481209 MAPK2 Mitogen-activated protein kinase-activated protein kinase 2 isoform 2 – 0.69 – nd nd nd
(Continued)
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TABLE 1 | Continued
Accession HGNC Name Cytosol Nucleus
T1L T3D T3-UV T1L T3D T3-UV
gi|119964726 MPRI Insulin-like growth factor 2 receptor precursor – 0.66 0.65 nd nd nd
gi|148727286 ACOT2 Acyl-CoA thioesterase 2 – 0.58 – nd nd nd
gi|5803011 ENOG Enolase 2 – – 0.80 nd nd nd
gi|28872792 CK5P3 CDK5 regulatory subunit associated protein 3 – – 0.77 nd nd nd
gi|4826870 NUCB2 Nucleobindin 2 – – 0.73 nd nd nd
gi|194578923 JIP4 Sperm associated antigen 9 isoform 1 – – 0.72 nd nd nd
gi|17921989 TBA4A Tubulin, alpha 4a – – 0.70 – – –
gi|4503363 DPM1 Dolichyl-phosphate mannosyltransferase 1 – – 0.68 nd nd nd
gi|29826287 RM47 Mitochondrial ribosomal protein L47 isoform a – – 0.62 nd nd nd
gi|54124343 FA21A Hypothetical protein LOC387680 – – 0.61 nd nd nd
gi|6912630 IFIT5 Interferon-induced protein with tetratricopeptide repeats 5 – – 0.60 nd nd nd
gi|162329583 CPSF6 Cleavage and polyadenylation specific factor 6, 68 kD subunit – – 0.58 – – –
gi|48255933 HMGN1 High-mobility group nucleosome binding domain 1 nd nd nd 0.61 – 0.34
gi|111955084 AZI1 5-Azacytidine induced 1 isoform a nd nd nd 0.57 – –
gi|68509926 DHX15 DEAH (Asp-Glu-Ala-His) box polypeptide 15 – – – 0.56 – –
gi|28173554 H2B3B Histone cluster 3, H2bb nd nd nd 0.54 0.50 0.44
gi|156523968 PARP1 Poly (ADP-ribose) polymerase family, member 1 – – – 0.53 – –
gi|40807485 PRP6 PRP6 pre-mRNA processing factor 6 homolog nd nd nd 0.53 – –
gi|5803137 RBM3 RNA binding motif protein 3 – – – 0.49 – 0.50
gi|4758112 DX39B HLA-B associated transcript 1 – – – 0.45 0.42 –
gi|10863945 XRCC5 ATP-dependent DNA helicase II – – – 0.44 – –
gi|5031749 HMGN2 High-mobility group nucleosomal binding domain 2 nd nd nd 0.43 – 0.24
gi|5453930 RPB9 DNA directed RNA polymerase II polypeptide I nd nd nd 0.42 0.43 0.37
gi|53793688 H32 Histone cluster 2, H3a nd nd nd 0.37 0.36 0.17
gi|66912162 H2B2F Histone cluster 2, H2bf isoform a nd nd nd 0.33 – 0.15
gi|16751921 DCD Dermcidin preproprotein nd nd nd 0.21 0.33 0.28
gi|114796646 RCC1 regulator of chromosome condensation 1 isoform b – – – – 0.57 –
gi|119226260 CHERP Calcium homeostasis endoplasmic reticulum protein nd nd nd – 0.56 0.61
gi|11968182 RS18 Ribosomal protein S18 – – – – 0.51 –
gi|156151394 HNRPR Heterogeneous nuclear ribonucleoprotein R isoform 1 nd nd nd – 0.43 –
gi|4504261 H2B1N Histone cluster 1, H2bn nd nd nd – 0.41 0.08
gi|4758950 PPIB Peptidylprolyl isomerase B precursor – – – – – 0.55
gi|16579885 RL4 Ribosomal protein L4 – – – – – 0.48
gi|14043072 ROA2 Heterogeneous nuclear ribonucleoprotein A2/B1 isoform B1 – – – – – 0.42
gi|4885379 H14 Histone cluster 1, H1e nd nd nd – – 0.35
gi|4504299 H31T Histone cluster 3, H3 nd nd nd – – 0.35
gi|4507353 RBP56 TBP-associated factor 15 isoform 2 nd nd nd – – 0.32
gi|20270186 HMGN3 High mobility group nucleosomal binding domain 3 isoform HMGN3a nd nd nd – – 0.24
gi|22208971 HMGA1 High mobility group AT-hook 1 isoform a nd nd nd – – 0.24
Red and pink indicate degrees of up-regulation; green indicates down-regulation; –, not significantly regulated; n.d., not detected; *Record removed from NCBI.
in T3D-infected cells but only weakly up-regulated in
corresponding T1L-infected and UV-T3D-treated cells
(Figure 2).
Cell Death and Survival, Cell Signaling, Infectious
Diseases and Interferon-Induced Pathways are
Differentially Induced by T1L, T3D, and UV-T3D
The differentially-regulated proteins were analyzed by a vari-
ety of software tools. Ingenuity Pathway Analyses (IPA) globally
mapped all genes into cytokines, enzymes, growth factors,
and other categories (Figure 3A). There were significant dif-
ferences in the proportions of enzymes, transcription regula-
tors, transporters, and other GO classes differentially regulated
by the three virus treatments (Figure 3A). Mapping up- and
down-regulated proteins into IPA networks identified nine net-
works that contained at least 12 focus molecules. The four
highest scoring networks were: cell signaling, dermatological
diseases and conditions, antimicrobial response (Figure 3B);
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STAT-1
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FIGURE 2 | Immunoblot analyses of indicated host proteins in HeLa
cells mock-infected, or infected with T3D or T1L, or treated with
UV-inactivated T3D. Cells were harvested and lysed with 0.5% NP-40
detergent, nuclei removed, and cytosolic fractions dissolved in SDS
electrophoresis sample buffer, resolved in 10% mini SDS-PAGE, transferred to
PVDF, and probed with various antibodies. Bands were visualized, and
intensities measured, with an Alpha Innotech FluorChem®Q MultiImage® III
instrument.
Organismal development, RNA post-transcriptional modifica-
tion, cardiovascular disease (Figure 3C); Cell death and sur-
vival, cell signaling, small molecule biochemistry (Figure 3D);
and Gene expression, cell cycle, infectious diseases (Figure 3E).
Additional major networks included: Cancer, Immunological
disease; Inflammatory disease and response; Tissue develop-
ment; DNA replication; and Cell cycle and cellular development
(Supplementary Figure S1). All networks showed significant
differences in the specific members that were up-regulated,
non-regulated, or down-regulated by T1L, T3D, or UV-T3D.
Similarly, IPA analysis identified numerous significantly-affected
canonical pathways. The Interferon signaling pathway was differ-
entially affected by the three different virus treatments (Figure 4).
As reflected by differences in respective protein levels (Table 1),
numerous members of this pathway were up-regulated by T3D
infection but not by T1L infection, and Mx1 and IFIT3 were
down-regulated by UV-T3D treatment. Representative addi-
tional canonical pathways, such as Activation of IRF by cytosolic
pattern recognition receptors, EIF2 signaling, ILK signaling,
and Mitochondrial dysfunction, were also differentially regu-
lated by the three different virus treatments (Supplementary
Figure S2).
T1L
T3D
B Cell Signaling, Dermatological Diseases &
        Conditions, Antimicrobial Response
C Organismal Development, RNA Post-Transcrip-
        tional Modi!cation, Cardiovascular Disease
UV-T3D
Total
T1L T3D UV-T3D
Up
Down
Cytokines
Enzymes
Growth factor
Ion channel
Kinase
Peptidase
Phosphatase
Transcription regulator
Translation regulator
Transmembrane receptor
Transporter
Other
A
D Cell Death & Survival, Cell Signaling, Small
       Molecule Biochemistry
E Gene Expression, Cell Cycle, Infectious
        Diseases
T1L
T3D
UV-T3D
FIGURE 3 | Molecular pathways of regulated proteins. Proteins and their
levels of regulation were imported into the Ingenuity Pathways Analysis (IPA®)
(Continued)
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FIGURE 3 | Continued
tool and interacting pathways were constructed. (A) Ontological
classifications of all measured proteins (Total) as well as those significantly
up- and down-regulated by each of the viruses. (B–E) The top four IPA
networks, identified at 95% confidence and each of which contained 12 or
more “focus” molecules (molecules significantly up- or down-regulated),
with pathway names indicated. Solid lines: direct known interactions;
dashed lines: suspected or indirect interactions. Significantly regulated
proteins identified in either the cytosolic or nuclear fractions were overlaid
onto each network; red, significantly up-regulated proteins; pink,
moderately up-regulated proteins; gray, proteins identified but not
significantly regulated; light green, moderately down-regulated proteins;
dark green, significantly down-regulated proteins; white, proteins known to
be in network, but not identified in our study. Molecular classes are
indicated in legend. Additional networks, also with 12 or more “focus”
molecules, are depicted in Supplementary Figure S1.
Discussion
Recent work by us and by others has begun to detect and mea-
sure quantitative differences in host mRNA and proteins induced
by MRV infection. Poggioli et al. (2002) identified numerous
cell cycle protein genes whose transcription was affected by
either T1L or type 3 Abney infection. O’donnell et al. (2006)
identified >100 interferon- and NF-κB-responsive genes that
were affected by T3D infection. Transcriptomic analyses of
MRVT3D- and flavivirus-infectedmurine brain tissues indicated
up-regulation of apoptosis, interferon, inflammation and cell
death/survival signaling and down-regulation of glutamate sig-
naling genes (Clarke et al., 2014). Global protein analyses, using
2D-DIGE/MS analyses of murine cardiac myocytes infected with
T1L, T3D, potently myocarditic reassortant 8B, and a non-
myocarditic derivative virus DB93A, identified several thousand
proteins and found 67 host proteins were differentially expressed
(p < 0.05) (Li et al., 2010). These proteins included Hsp25
and proteins associated with amino acid metabolism, calcium
signaling, ERK/ MAPK signaling, mitochondrial dysfunction,
oxidative stress, and protein ubiquitination. Myocarditic reas-
sortant virus 8B was also uniquely associated with regulation
of proteins involved in endoplasmic reticulum stress and phos-
pholipid degradation. Non-gel-based SILAC analyses of indi-
vidual MRV clones identified 104 differentially expressed host
proteins in T1L-infected HEK-293 cells at 6 or 24 hpi (Berard
et al., 2012), and 133 (Jiang et al., 2012) and 89 (Coombs,
2013) differentially expressed proteins in T3D-infected HeLa
cells. We also very recently analyzed host protein alterations in
HEK-293 cells infected with each of two different T3D clones
(Berard et al., accepted). Up-regulated proteins in these studies
were associated with antimicrobial and antiviral responses, cell
death and growth factors, GTPase activity, nucleotide binding,
oxygen transport, interferon signaling, and enzymes associated
with energy generation. Down-regulated proteins included those
involved in apoptosis, cell and biological adhesion, isomerase
activity, macromolecular catabolic activity, regulation of cell pro-
liferation, structural molecule activity, and numerous molecular
binding activities. Not all processes were affected by all virus types
or in different cell types. Thus, the current study was undertaken
to directly compare two virus serotypes, and live vs. dead T3D,
in a common cell type that had been previously used. Compar-
isons of the results obtained in the current study with a previ-
ous SILAC assay of the same virus/cell system (Coombs, 2013)
indicated that 1711 common proteins were identified and mea-
sured in both studies. There was good correlation between the
two studies. Seven proteins (Mx1, ISG15, IFIT1, IFIT3, STAT1,
E2AK2, and TYPH) were determined as up-regulated by both
assays. 1660 proteins were indicated as not significantly regulated
in both assays and no proteins were indicated as significantly
up-regulated in one assay but down-regulated in the other.
As has been observed in earlier studies, T1L and T3D differ-
entially induce host protein responses. This has been observed
both in the single previous global proteomic screen (Li et al.,
2010), and in more targeted analyses that focused on individ-
ual molecules or small sets of molecules, including a study by
Tyler and colleagues demonstrating that the T3D S1 gene, which
encodes viral attachment protein σ1, is associated with larger
apoptosis induction in L929 cells (Tyler et al., 1995), a study
by Sherry and colleagues that showed that viral core proteins
λ2, µ2, and σ2 were associated with IFN-β induction in car-
diac myocyte cultures (Sherry et al., 1998), a study by Clarke
and colleagues that revealed that the T3D S1 and M2 genes
(encoding σ1 and µ1, respectively) were associated with apop-
tosis and JNK activation (Clarke et al., 2001), a study by Miller
and colleagues that demonstrated that protein ubiquitination was
more greatly enhanced in CV-1 cells infected with MRV clones
that contained primarily the T3D µ2 protein, with some con-
tribution by the λ2 and λ3 proteins (Miller et al., 2004), and a
study by Zurney and colleagues that demonstrated the T1L µ2
protein represses IFN-mediated induction of various interferon-
stimulated genes in L929 cells and leads to IRF9 accumulation
in the nucleus (Zurney et al., 2009). The present study con-
tributes a large number of cellular proteins that are differentially
regulated by T1L and T3D. Seventeen host proteins (11 in the
cytosol and six in the nucleus) are up-regulated ≥1.5-fold by
T1L infection but not by T3D infection. Most of these uniquely
T1L-induced up-regulated proteins (1433E, 2AAA, BAF, CAPR1,
CH60, DHAK, EF2, ERH, H2B1M, MATR3, SCOC, SYIC, and
U2AF2, and the ribosomal proteins RM10, RM44, and RS7) are
involved in binding variousmolecules including ATP, DNA, RNA
and/or protein. BAF, CH60, and 1433E have previously been
implicated in virus-host interactions. Two proteins (BAF and
H2B1M) are involved in chromatin structure/organization and
one protein (H2B1M) is also involved in DNA damage/repair.
Sixteen host proteins (seven in the cytosol and nine in the
nucleus) are down-regulated ≥1.5-fold (to ≤0.667) by T1L
infection but not by T3D infection. These include five pro-
teins (H2AY, H2B2F, HMGN1, HMGN2, and PARP1) involved
in chromatin structure/organization and four proteins (H2B2F,
HMGN1, PARP1, XRCC5) involved in DNA damage/repair.
Many T1L-induced down-regulated proteins (DHX15, HMGN2,
PARP1, PRP6, RBM3, SRSF2, and XRCC5) are involved in RNA
binding/processing/splicing. Twenty four host proteins (17 in the
cytosol and seven in the nucleus) are up-regulated ≥1.5-fold by
T3D infection but not by T1L infection, and four of these pro-
teins (Mx1, ISG15, IFIT1, and STAT1) are up-regulated>3.5-fold
by T3D. The T3D-induced highly up-regulated proteins (Mx1,
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T1L
T3D
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FIGURE 4 | Significantly affected canonical pathway “interferon
signaling”, as determined by IPA® analysis. Red indicates highly
up-regulated proteins, light green indicates down-regulated, gray represents
not significantly affected, and white represents molecules known to be part
of the pathway but not identified by iTRAQ. Examples of additional affected
canonical pathways are depicted in Supplementary Figure S2.
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ISG15, IFIT1, and STAT1) and two other proteins (IFIT3 and
DDX58) are involved in interferon signaling. Numerous T3D-
induced up-regulated proteins are also associated with apop-
tosis (ACTN4, IFIT3, Mx1, and STAT1) and either anti-viral
responses or virus-host interactions (AP2A1, CH60, DDX58,
ELOA1, IFIT1, IFIT3, ISG15, Mx1, RBP2, and STAT1). No T3D-
induced up-regulated proteins are associated with chromatin
structure/organization or RNA processing/splicing, although
five T3D-induced down-regulated proteins (DEK, H2B1N, H4,
HNRPR, and RCC1) are associated with those functions. In addi-
tion, of the 10 proteins (four in the cytosol and six in the nucleus)
that are down-regulated ≥1.5-fold by T3D infection but not by
T1L infection, DEK, RCC1, and RS18 have been associated with
viral processes.
Viruses are notable for inducing a variety of alterations in
their host cells, ranging from asymptomatic in some cases to
highly pathogenic in others. Different strains of the same virus
can also induce differences in pathology. Although the reovirus
T1L strain often produces higher titers at initial sites of infec-
tion than the T3D strain (Farone et al., 1996), the strains travel
by different routes to the murine brain and induce different dis-
eases, with T3D usually leading to more lethal infection (Tyler
et al., 1986; Tyler, 1998). These observations correlate with our
observation that T3D induced more host protein dysregulation
than T1L, particularly in immune regulatory molecules (Table 1).
These cellular protein alterations may also play a role in oncolytic
potential of reovirus. Enhanced oncolytic potential is based upon
cellular activation, including ras activation (Strong et al., 1998),
p53 stabilization (Pan et al., 2011), and cathepsin activity levels
(Terasawa et al., 2015), some of which play roles in apoptosis
(Pan et al., 2011) and autophagy (Thirukkumaran et al., 2013),
processes found to be altered in this study.
In conclusion, comparative iTRAQ analyses demonstrate that
reoviruses T1L and T3D induce different proteomic responses
in infected HeLa cells, with the T3D clone inducing higher
dysregulation of various cellular signaling pathways.
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